Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection

Recruiting

Phase 2

TP-102Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection

Sponsor:

Technophage, SA

Code:

NCT05948592

Conditions

Diabetic Foot Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TP-102

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Technophage, SA on 2024-08-05.